Associated Papers
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.
Graillon T et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
38630553 (PubMed )
Supplement: ccr-23-3308_supplementary_table_s1_suppts1.xlsx › Feuil1
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
Youngblood MW et al.
Nature Communications, 2023
37805627 (PubMed )
Supplement: 41467_2023_41926_MOESM3_ESM.xlsx › SD1
Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS et al.
Brain Pathology (zurich, Switzerland), 2022
35213082 (PubMed )
Supplement: BPA-32-e12970-s001.xlsx › Sheet1
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
González-Tablas M et al.
Frontiers in Oncology, 2021
34868937 (PubMed )
Supplement: DataSheet_1.docx
Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Harmancı AS et al.
Nature Communications, 2017
28195122 (PubMed )
Supplement: ncomms14433-s3.xlsx › Table_S2D
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Clark VE et al.
Science (new York, N.y.), 2013
Select a paper to view details